Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 4 Study of Randomized Comparison Among Oral Rapamycin Plus Bare Metal Stents Versus Drug Eluting Stents in de Novo Coronary Lesions.

NCT00552669 is registered in ClinicalTrials.gov with Centro de estudios en Cardiologia Intervencionista as lead sponsor.

NCT NCT00552669
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00552669 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 4 Study of Randomized Comparison Among Oral Rapamycin Plus Bare Metal Stents Versus Drug Eluting Stents in de Novo Coronary Lesions.
Lead sponsor
Centro de estudios en Cardiologia Intervencionista
Phase
Phase 4
Overall status
Completed
Start date
January 31, 2006
Completion date
September 30, 2007
Enrollment
200 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

coronary heart disease, coronary restenosis